Home › Funds › Strategic Planning, Inc. › CVS
Strategic Planning, Inc. position in CVS
CVS HEALTH CORP · Consumer Staples
Strategic Planning, Inc. reported holding 146,342 shares of CVS (CVS HEALTH CORP) in its Q1 2026 13F filing — a position valued at US$10.5M, representing 5.27% of its reported portfolio and ranking #6 among its reported holdings. Strategic Planning, Inc. has disclosed CVS holdings in 5 of the last 5 reported quarters, going back to Q1 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Strategic Planning, Inc.'s CVS position evolved
Strategic Planning, Inc. first disclosed a stake in CVS in Q1 2025 at 145,437 shares (US$9.9M). The position peaked in Q4 2025 at 144,609 shares, worth US$11.5M. Across 5 filings, Strategic Planning, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q1 2026) shows 146,342 shares valued at US$10.5M — an increase of 1,733 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 145.44K | $9.85M | New |
| Q2 2025 | 143.21K | $9.88M | Reduce |
| Q3 2025 | 144.45K | $10.89M | Add |
| Q4 2025 | 144.61K | $11.48M | Hold |
| Q1 2026 | 146.34K | $10.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Strategic Planning, Inc.
FAQ
How long has Strategic Planning, Inc. held CVS?
Strategic Planning, Inc. has disclosed CVS holdings in 5 of the last 5 reported quarters, going back to Q1 2025.
What is Strategic Planning, Inc.'s current position in CVS?
As of Q1 2026, Strategic Planning, Inc. holds 146.34K shares of CVS (CVS HEALTH CORP), valued at $10.51M, representing 5.27% of its reported portfolio and ranking #6.
Has Strategic Planning, Inc. been buying or selling CVS?
In the latest 13F filing (Q1 2026), Strategic Planning, Inc. increased its position in CVS. The position peaked in Q4 2025 at 144.61K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.